Prof. Dr. med. Roland Schmieder



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial (2022) Mahfoud F, Kandzari DE, Kario K, Townsend RR, Weber MA, Schmieder R, Tsioufis K, et al. Journal article The authors reply (2022) Ott C, Schmieder R Journal article Renal denervation: where do we stand and what is the relevance to the nephrologist? (2022) Schmieder R Journal article, Review article Effects of cardiovascular single pill combinations compared with identical multi-pill therapies on healthcare cost and utilization in Germany (2022) Wilke T, Weisser B, Predel HG, Schmieder R, Wassmann S, Gillessen A, Blettenberg J, et al. Journal article Clinical Trial Design Principles and Outcomes Definitions for Device-Based Therapies for Hypertension: A Consensus Document From the Hypertension Academic Research Consortium (2022) Kandzari DE, Mahfoud F, Weber MA, Townsend R, Parati G, Fisher NDL, Lobo MD, et al. Journal article Plasma renin and aldosterone concentrations related to endovascular ultrasound renal denervation in the RADIANCE-HTN SOLO trial (2022) Fisher ND, Kirtane AJ, Daemen J, Rader F, Lobo MD, Saxena M, Abraham J, et al. Journal article Renal denervation in patients with versus without chronic kidney disease: results from the Global SYMPLICITY Registry with follow-up data of 3 years (2022) Ott C, Mahfoud F, Mancia G, Narkiewicz K, Ruilope LM, Fahy M, Schlaich MP, et al. Journal article Renal denervation Really an alternative to reducing blood pressure? (2022) Striepe K, Schiffer M, Schmieder R Journal article Effects of treatment with SGLT-2 inhibitors on arginine-related cardiovascular and renal biomarkers (2022) Geßner A, Gemeinhardt A, Bosch A, Kannenkeril D, Staerk C, Mayr A, Fromm M, et al. Journal article NT-proBNP and stem cell factor plasma concentrations are independently associated with cardiovascular outcomes in end-stage renal disease hemodialysis patients. (2022) Rossignol P, Duarte K, Bresso E, Åsberg A, Devignes MD, Eriksson N, Girerd N, et al. Journal article